Literature DB >> 27143547

Should Chronic Total Occlusion Be Treated With Coronary Artery Bypass Grafting? Chronic Total Occlusion Should Be Treated With Coronary Artery Bypass Grafting.

Mustafa Zakkar1, Sarah J George1, Raimondo Ascione2.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27143547     DOI: 10.1161/CIRCULATIONAHA.115.017797

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

1.  Relationship of myocardial hibernation, scar, and angiographic collateral flow in ischemic cardiomyopathy with coronary chronic total occlusion.

Authors:  Li Wang; Min-Jie Lu; Lei Feng; Juan Wang; Wei Fang; Zuo-Xiang He; Ke-Fei Dou; Shi-Hua Zhao; Min-Fu Yang
Journal:  J Nucl Cardiol       Date:  2018-03-07       Impact factor: 5.952

2.  Effect of revascularization on coronary chronic total occlusion in patients undergoing coronary artery bypass grafting.

Authors:  Jiyun Lee; Yun Seok Kim; Hwan Wook Kim; Joon Kyu Kang; Hyun Song; Ju Yong Lim
Journal:  J Thorac Dis       Date:  2021-11       Impact factor: 2.895

3.  Commentary: Grafting the occluded right coronary artery: The sunny side of the street.

Authors:  Erin M Schumer; Phillip G Rowse
Journal:  JTCVS Open       Date:  2021-07-02

4.  Left Main Coronary Artery Disease and Outcomes after Percutaneous Coronary Intervention for Chronic Total Occlusions.

Authors:  Max-Paul Winter; Georg Goliasch; Philipp Bartko; Jolanta Siller-Matula; Mohamed Ayoub; Stefan Aschauer; Klaus Distelmaier; Catherine Gebhard; Kambis Mashayekhi; Miroslaw Ferenc; Christian Hengstenberg; Aurel Toma
Journal:  J Clin Med       Date:  2020-03-30       Impact factor: 4.241

5.  Human coronary microvascular contractile dysfunction associates with viable synthetic smooth muscle cells.

Authors:  Kim A Dora; Lyudmyla Borysova; Xi Ye; Chloe Powell; Timea Z Beleznai; Christopher P Stanley; Vito D Bruno; Tobias Starborg; Errin Johnson; Anna Pielach; Michael Taggart; Nicola Smart; Raimondo Ascione
Journal:  Cardiovasc Res       Date:  2022-06-29       Impact factor: 13.081

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.